IBD: Can TNF inhibitors be administered during the third trimester?

    loading  Checking for direct PDF access through Ovid

Abstract

As pregnancies frequently occur in patients with IBD, and given that TNF inhibitors are increasingly being used for treatment of this chronic intestinal disease, the discontinuation of biologic agents during the third trimester in patients with quiescent disease has been advocated owing to safety concerns.

Related Topics

    loading  Loading Related Articles